{"id":"W2404273804","doi":"10.2337/dc16-0014","title":"Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial","year":2016,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Diabetes Management and Research","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Sanofi","keywords":"Lixisenatide; Medicine; Insulin glargine; Metformin; Postprandial; Internal medicine; Type 2 diabetes; Endocrinology; Diabetes mellitus; Hypoglycemia; Insulin; Exenatide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001456701,0.0009226661,0.001339496,0.0008940423,0.0004197588,0.0002436541,0.001045816,0.0004257526,0.00101113],"category_scores_gemma":[0.006262131,0.0005610961,0.000334905,0.002988618,0.0004177694,0.0005545153,0.0006607574,0.0009762136,0.001178539],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008452006,"about_ca_system_score_gemma":0.00116101,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007555809,"about_ca_topic_score_gemma":0.0002167952,"domain_scores_codex":[0.9932384,0.0005985108,0.001191378,0.001369032,0.001544161,0.00205844],"domain_scores_gemma":[0.9938287,0.002824764,0.0003275218,0.001413402,0.0009329075,0.0006727726],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2574876,0.002802405,0.1114734,0.001379059,0.002476247,0.0006896766,0.00663418,0.002008748,0.01816249,0.0003678734,0.02284783,0.5736704],"study_design_scores_gemma":[0.6147677,0.03582776,0.1612142,0.005321146,0.0009874863,0.000002510776,0.004487047,0.01028727,0.01926534,0.001121128,0.1418486,0.004869817],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9745221,0.005616996,0.00002646299,0.008360771,0.002653136,0.004948485,0.000238097,0.0003204407,0.003313515],"genre_scores_gemma":[0.986604,0.0009145262,0.00160467,0.0037244,0.003000477,0.001011322,0.0002976754,0.0003154306,0.002527501],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5688007,"threshold_uncertainty_score":0.9999021,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04099367259727368,"score_gpt":0.3202192885146405,"score_spread":0.2792256159173668,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}